Laboratorios Farmaceuticos ROVI (ROVI)

39.800
+1.300(+3.38%)
  • Volume:
    356,559
  • Bid/Ask:
    36.160/36.900
  • Day's Range:
    38.520 - 39.840

ROVI Overview

Prev. Close
39.8
Day's Range
38.52-39.84
Revenue
934.13M
Open
38.64
52 wk Range
35.2-74.9
EPS
3.29
Volume
356,559
Market Cap
2.12B
Dividend (Yield)
0.774
(2.11%)
Average Vol. (3m)
243,348
P/E Ratio
12.06
Beta
0.447
1-Year Change
-37.81%
Shares Outstanding
53,374,867
Next Earnings Date
Feb 22, 2023
What is your sentiment on Laborat.Rovi?
or
Market is currently closed. Voting is open during market hours.

Laboratorios Farmaceuticos ROVI News

Laboratorios Farmaceuticos ROVI Analysis

Laboratorios Farmaceuticos ROVI Company Profile

Laboratorios Farmaceuticos ROVI Company Profile

Employees
1852
Market
Spain
  • Type:Equity
  • Market:Spain
  • ISIN:ES0157261019

Laboratorios Farmaceuticos ROVI SA (ROVI) is a Spain-based company principally engaged in the pharmaceutical industry. The Company’s main activities include the development and commercialization, nationwide and abroad, of medicines and drugs. Its products are structured into three fields: Diagnostic, which offers contrast mediums for use in magnetic resonance, ultrasound and X-ray diagnostics; Prescription, which distributes medicines under such brands as Hibor, Osseor, Hepadren, Pneumovax-23, Glufan, Corlentor, Exxiv, Calcio y Vitamina D3 Rovi and Absorcol, among others; and Over The Counter (OTC), which comprises the Perspirex, Enerzona, Dentimelo and ColdPack brands. The Company owns such fully consolidated subsidiaries as Gineladius SL, Frosst Iberica SA, Rovi Contract Manufacturing SL and Bertex Pharma GmbH, among others.

Read More

Analyst Price Target

Average63.056 (+58.432% Upside)
High74.000
Low52.000
Price39.800
No. of Analysts9
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuySell
Technical IndicatorsBuyBuyBuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
  • at 100e
    1
    • rovi at ibex?????
      1
      • Finally yes!
        0
    • ??? ibex 35
      1
      • up ibex 35
        1
        • at 100e
          1
          • Rovi now has not crazy fundamentals, but I like it for the same reason I liked Jinko Solar in August. You can't have a brain that is worth 40 and a muscle that is worth 1.5. Biotechs are the brain, Rovi is the muscle and will heavily profit from the success of that brain since is the executor arm. Jinko Solar in solar is the muscle, solaredge and enphase the brain.
            1
            • And an interesting pattern is, brain stock raise is always before the muscle one, so catching cheap muscles is as easy as detecting growing brains
              1